Should we practice stem cell therapy for type 1 diabetes mellitus as precision medicine?

Authors:
Dr. Umang G Thakkar, DCH
Dr. Umang G Thakkar, DCH
Institute of Kidney Diseases and Research Centre and Institute of Transplantation Sciences
Associate Prof.
General pediatrics as well as neonatology
Ahmedabad, Gujarat | India
Aruna V Vanikar
Aruna V Vanikar
Department of Nephrology and Clinical Transplantation
India
Hargovind L Trivedi
Hargovind L Trivedi
Department of Nephrology and Clinical Transplantation
India

Cytotherapy 2017 05 2;19(5):574-576. Epub 2017 Mar 2.

Department of Regenerative Medicine and Stem Cell Therapy, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC), Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India; Nephrology and Transplantation Medicine, G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre, Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), Gujarat, India.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2017.02.001DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
May 2017
103 Reads
3.293 Impact Factor

Publication Analysis

Top Keywords

type diabetes
4
diabetes mellitus
4
mellitus precision
4
precision medicine?
4
cell therapy
4
therapy type
4
stem cell
4
practice stem
4
precision
1
medicine?
1
cell
1
mellitus
1
practice
1
diabetes
1
therapy
1
type
1

Similar Publications